Inhaled steroid 'speeds recovery' in mild COVID-19

Promising early trial results might prove to be a significant milestone, researchers say

Treating COVID-19 patients at home with inhaled budesonide can speed their recovery, according to preliminary results from a UK trial.

The researchers behind the PRINCIPLE trial said the findings, yet to be peer-reviewed, might lead doctors to prescribe budesonide inhalers to patients with COVID-19 who were not sick enough to be hospitalised.

The study involved 961 patients who were randomly assigned to receive inhaled budesonide and compared with 1819 patients